Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

What are the practitioner-level determinants for inappropriate PSA testing?

Nature Clinical Practice Urology volume 5, pages 70–71 (2008)Cite this article

boxed-textKerfoot BP et al. (2007) Practitioner-level determinants of inappropriate prostate-specific antigen screening. Arch Intern Med 167: 1367–1372

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Stamey TA et al. (1987) Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317: 909–916

    Article  CAS  Google Scholar 

  2. Postma R et al. (2007) Cancer detection and cancer characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC)—Section Rotterdam. A comparison of two rounds of screening. Eur Urol 52: 89–97

    Article  Google Scholar 

  3. Donovan J et al. (2003) Prostate Testing for Cancer and Treatment (ProtecT) feasibility study. Health Technol Assess 7: 1–88

    Article  CAS  Google Scholar 

  4. Bratt O (2002) Hereditary prostate cancer: clinical aspects. J Urol 168: 906–913

    Article  Google Scholar 

  5. Thompson IM et al. (2004) Prevalence of prostate cancer among men with a prostate-specific antigen level ≥4.0 ng per milliliter. N Engl J Med 350: 2239–2246

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Murphy, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Academic Urology Unit, University of Sheffield, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UK f.c.hamdy@sheffield.ac.uk

Authors and Affiliations

  1. FC Hamdy is a Professor, and Head of Urology and Oncology at the University of Sheffield School of Medicine and Biomedical Sciences, Sheffield, UK.,

    Freddie C Hamdy

Authors
  1. Freddie C Hamdy
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hamdy, F. What are the practitioner-level determinants for inappropriate PSA testing?. Nat Rev Urol 5, 70–71 (2008). https://doi.org/10.1038/ncpuro0990

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0990

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing